Betamethasone Ointment Market to Witness Astonishing Growth by 2029
Betamethasone Ointment Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market during the forecast period include increasing incidences of skin disorders such as psoriasis, rising incidences of asthma, surge in cancer patients, and rising incidences of rheumatoid disorders such as rheumatoid arthritis and systemic lupus erythematosus. Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes).
Betamethasone belongs to a class of medications
called corticosteroids. It works by activating natural substances in the skin
to reduce swelling, redness, and itching. Furthermore, the advent of different
formulations of betamethasone and untapped market opportunities in emerging
nations will further boost the market growth. In order to maintain a strong
position in the market, these market players are adopting various strategic
moves, such as product launches, partnerships and collaborations, and mergers
and acquisitions. For instance, in March 2020, Lupin Ltd. declared the launch
of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%, having received
an approval from the US Food and Drug Administration (US FDA) earlier. The
product would be manufactured at Lupin’s Pithampur (Unit III) facility, India.
It is the generic equivalent of Diprolene Ointment, 0.05%, of Merck Sharp and
Dohme Corp. It is a corticosteroid indicated for the relief of the inflammatory
and pruritic manifestations of corticosteroid-responsive dermatoses in patients
13 years of age and older.
To Request a Sample of our Report on Betamethasone
Ointment Market: https://www.omrglobal.com/request-sample/betamethasone-ointment-market
Market Coverage
• The market number
available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
• By Type
Regions covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
Competitive Landscape: GlaxoSmithKline plc, Merck
& Co., Inc., and Cipla Inc., among others.
A
full Report of Betamethasone Ointment
Market is Available @
https://www.omrglobal.com/industry-reports/betamethasone-ointment-market
Betamethasone Ointment Market Report by Segment
By Type
• Betamethasone Dipropionate
• Betamethasone Sodium Phosphate
• Betamethasone Valerate
Global Betamethasone Ointment Market Report by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/betamethasone-ointment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and
consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and
Consulting Services through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment